Electric Therapy Traction Table Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 112 |
The global Live and Attenuated Vaccine market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Pediatric Vaccine Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Live and Attenuated Vaccine include GlaxoSmithKline, Merck & Co., Pfizer, Inc, Astellas Pharma Inc, Johnson & Johnson, CSL Limited, Emergent BioSolutions, Inc., MedImmune, LLC and Sanofi, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Live and Attenuated Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Live and Attenuated Vaccine. This report contains market size and forecasts of Live and Attenuated Vaccine in global, including the following market information:
Global Live and Attenuated Vaccine Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Live and Attenuated Vaccine Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Live and Attenuated Vaccine companies in 2022 (%)
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Live and Attenuated Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Live and Attenuated Vaccine Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Live and Attenuated Vaccine Market Segment Percentages, by Type, 2022 (%)
Pediatric Vaccine
Adult Vaccines
Global Live and Attenuated Vaccine Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Live and Attenuated Vaccine Market Segment Percentages, by Application, 2022 (%)
Hospitals
Clinics
Diagnostic Centers
Research Institute
Others
Global Live and Attenuated Vaccine Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Live and Attenuated Vaccine Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Live and Attenuated Vaccine revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Live and Attenuated Vaccine revenues share in global market, 2022 (%)
Key companies Live and Attenuated Vaccine sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Live and Attenuated Vaccine sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
GlaxoSmithKline
Merck & Co.
Pfizer, Inc
Astellas Pharma Inc
Johnson & Johnson
CSL Limited
Emergent BioSolutions, Inc.
MedImmune, LLC
Sanofi
Serum Institute
Outline of Major Chapters:
Chapter 1: Introduces the definition of Live and Attenuated Vaccine, market overview.
Chapter 2: Global Live and Attenuated Vaccine market size in revenue and volume.
Chapter 3: Detailed analysis of Live and Attenuated Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Live and Attenuated Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Live and Attenuated Vaccine capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Live and Attenuated Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Live and Attenuated Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Live and Attenuated Vaccine Overall Market Size
2.1 Global Live and Attenuated Vaccine Market Size: 2022 VS 2029
2.2 Global Live and Attenuated Vaccine Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Live and Attenuated Vaccine Sales: 2018-2029
3 Company Landscape
3.1 Top Live and Attenuated Vaccine Players in Global Market
3.2 Top Global Live and Attenuated Vaccine Companies Ranked by Revenue
3.3 Global Live and Attenuated Vaccine Revenue by Companies
3.4 Global Live and Attenuated Vaccine Sales by Companies
3.5 Global Live and Attenuated Vaccine Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Live and Attenuated Vaccine Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Live and Attenuated Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Live and Attenuated Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Live and Attenuated Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Live and Attenuated Vaccine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Live and Attenuated Vaccine Market Size Markets, 2022 & 2029
4.1.2 Pediatric Vaccine
4.1.3 Adult Vaccines
4.2 By Type - Global Live and Attenuated Vaccine Revenue & Forecasts
4.2.1 By Type - Global Live and Attenuated Vaccine Revenue, 2018-2023
4.2.2 By Type - Global Live and Attenuated Vaccine Revenue, 2024-2029
4.2.3 By Type - Global Live and Attenuated Vaccine Revenue Market Share, 2018-2029
4.3 By Type - Global Live and Attenuated Vaccine Sales & Forecasts
4.3.1 By Type - Global Live and Attenuated Vaccine Sales, 2018-2023
4.3.2 By Type - Global Live and Attenuated Vaccine Sales, 2024-2029
4.3.3 By Type - Global Live and Attenuated Vaccine Sales Market Share, 2018-2029
4.4 By Type - Global Live and Attenuated Vaccine Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Live and Attenuated Vaccine Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Diagnostic Centers
5.1.5 Research Institute
5.1.6 Others
5.2 By Application - Global Live and Attenuated Vaccine Revenue & Forecasts
5.2.1 By Application - Global Live and Attenuated Vaccine Revenue, 2018-2023
5.2.2 By Application - Global Live and Attenuated Vaccine Revenue, 2024-2029
5.2.3 By Application - Global Live and Attenuated Vaccine Revenue Market Share, 2018-2029
5.3 By Application - Global Live and Attenuated Vaccine Sales & Forecasts
5.3.1 By Application - Global Live and Attenuated Vaccine Sales, 2018-2023
5.3.2 By Application - Global Live and Attenuated Vaccine Sales, 2024-2029
5.3.3 By Application - Global Live and Attenuated Vaccine Sales Market Share, 2018-2029
5.4 By Application - Global Live and Attenuated Vaccine Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Live and Attenuated Vaccine Market Size, 2022 & 2029
6.2 By Region - Global Live and Attenuated Vaccine Revenue & Forecasts
6.2.1 By Region - Global Live and Attenuated Vaccine Revenue, 2018-2023
6.2.2 By Region - Global Live and Attenuated Vaccine Revenue, 2024-2029
6.2.3 By Region - Global Live and Attenuated Vaccine Revenue Market Share, 2018-2029
6.3 By Region - Global Live and Attenuated Vaccine Sales & Forecasts
6.3.1 By Region - Global Live and Attenuated Vaccine Sales, 2018-2023
6.3.2 By Region - Global Live and Attenuated Vaccine Sales, 2024-2029
6.3.3 By Region - Global Live and Attenuated Vaccine Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Live and Attenuated Vaccine Revenue, 2018-2029
6.4.2 By Country - North America Live and Attenuated Vaccine Sales, 2018-2029
6.4.3 US Live and Attenuated Vaccine Market Size, 2018-2029
6.4.4 Canada Live and Attenuated Vaccine Market Size, 2018-2029
6.4.5 Mexico Live and Attenuated Vaccine Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Live and Attenuated Vaccine Revenue, 2018-2029
6.5.2 By Country - Europe Live and Attenuated Vaccine Sales, 2018-2029
6.5.3 Germany Live and Attenuated Vaccine Market Size, 2018-2029
6.5.4 France Live and Attenuated Vaccine Market Size, 2018-2029
6.5.5 U.K. Live and Attenuated Vaccine Market Size, 2018-2029
6.5.6 Italy Live and Attenuated Vaccine Market Size, 2018-2029
6.5.7 Russia Live and Attenuated Vaccine Market Size, 2018-2029
6.5.8 Nordic Countries Live and Attenuated Vaccine Market Size, 2018-2029
6.5.9 Benelux Live and Attenuated Vaccine Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Live and Attenuated Vaccine Revenue, 2018-2029
6.6.2 By Region - Asia Live and Attenuated Vaccine Sales, 2018-2029
6.6.3 China Live and Attenuated Vaccine Market Size, 2018-2029
6.6.4 Japan Live and Attenuated Vaccine Market Size, 2018-2029
6.6.5 South Korea Live and Attenuated Vaccine Market Size, 2018-2029
6.6.6 Southeast Asia Live and Attenuated Vaccine Market Size, 2018-2029
6.6.7 India Live and Attenuated Vaccine Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Live and Attenuated Vaccine Revenue, 2018-2029
6.7.2 By Country - South America Live and Attenuated Vaccine Sales, 2018-2029
6.7.3 Brazil Live and Attenuated Vaccine Market Size, 2018-2029
6.7.4 Argentina Live and Attenuated Vaccine Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Live and Attenuated Vaccine Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Live and Attenuated Vaccine Sales, 2018-2029
6.8.3 Turkey Live and Attenuated Vaccine Market Size, 2018-2029
6.8.4 Israel Live and Attenuated Vaccine Market Size, 2018-2029
6.8.5 Saudi Arabia Live and Attenuated Vaccine Market Size, 2018-2029
6.8.6 UAE Live and Attenuated Vaccine Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 GlaxoSmithKline
7.1.1 GlaxoSmithKline Company Summary
7.1.2 GlaxoSmithKline Business Overview
7.1.3 GlaxoSmithKline Live and Attenuated Vaccine Major Product Offerings
7.1.4 GlaxoSmithKline Live and Attenuated Vaccine Sales and Revenue in Global (2018-2023)
7.1.5 GlaxoSmithKline Key News & Latest Developments
7.2 Merck & Co.
7.2.1 Merck & Co. Company Summary
7.2.2 Merck & Co. Business Overview
7.2.3 Merck & Co. Live and Attenuated Vaccine Major Product Offerings
7.2.4 Merck & Co. Live and Attenuated Vaccine Sales and Revenue in Global (2018-2023)
7.2.5 Merck & Co. Key News & Latest Developments
7.3 Pfizer, Inc
7.3.1 Pfizer, Inc Company Summary
7.3.2 Pfizer, Inc Business Overview
7.3.3 Pfizer, Inc Live and Attenuated Vaccine Major Product Offerings
7.3.4 Pfizer, Inc Live and Attenuated Vaccine Sales and Revenue in Global (2018-2023)
7.3.5 Pfizer, Inc Key News & Latest Developments
7.4 Astellas Pharma Inc
7.4.1 Astellas Pharma Inc Company Summary
7.4.2 Astellas Pharma Inc Business Overview
7.4.3 Astellas Pharma Inc Live and Attenuated Vaccine Major Product Offerings
7.4.4 Astellas Pharma Inc Live and Attenuated Vaccine Sales and Revenue in Global (2018-2023)
7.4.5 Astellas Pharma Inc Key News & Latest Developments
7.5 Johnson & Johnson
7.5.1 Johnson & Johnson Company Summary
7.5.2 Johnson & Johnson Business Overview
7.5.3 Johnson & Johnson Live and Attenuated Vaccine Major Product Offerings
7.5.4 Johnson & Johnson Live and Attenuated Vaccine Sales and Revenue in Global (2018-2023)
7.5.5 Johnson & Johnson Key News & Latest Developments
7.6 CSL Limited
7.6.1 CSL Limited Company Summary
7.6.2 CSL Limited Business Overview
7.6.3 CSL Limited Live and Attenuated Vaccine Major Product Offerings
7.6.4 CSL Limited Live and Attenuated Vaccine Sales and Revenue in Global (2018-2023)
7.6.5 CSL Limited Key News & Latest Developments
7.7 Emergent BioSolutions, Inc.
7.7.1 Emergent BioSolutions, Inc. Company Summary
7.7.2 Emergent BioSolutions, Inc. Business Overview
7.7.3 Emergent BioSolutions, Inc. Live and Attenuated Vaccine Major Product Offerings
7.7.4 Emergent BioSolutions, Inc. Live and Attenuated Vaccine Sales and Revenue in Global (2018-2023)
7.7.5 Emergent BioSolutions, Inc. Key News & Latest Developments
7.8 MedImmune, LLC
7.8.1 MedImmune, LLC Company Summary
7.8.2 MedImmune, LLC Business Overview
7.8.3 MedImmune, LLC Live and Attenuated Vaccine Major Product Offerings
7.8.4 MedImmune, LLC Live and Attenuated Vaccine Sales and Revenue in Global (2018-2023)
7.8.5 MedImmune, LLC Key News & Latest Developments
7.9 Sanofi
7.9.1 Sanofi Company Summary
7.9.2 Sanofi Business Overview
7.9.3 Sanofi Live and Attenuated Vaccine Major Product Offerings
7.9.4 Sanofi Live and Attenuated Vaccine Sales and Revenue in Global (2018-2023)
7.9.5 Sanofi Key News & Latest Developments
7.10 Serum Institute
7.10.1 Serum Institute Company Summary
7.10.2 Serum Institute Business Overview
7.10.3 Serum Institute Live and Attenuated Vaccine Major Product Offerings
7.10.4 Serum Institute Live and Attenuated Vaccine Sales and Revenue in Global (2018-2023)
7.10.5 Serum Institute Key News & Latest Developments
8 Global Live and Attenuated Vaccine Production Capacity, Analysis
8.1 Global Live and Attenuated Vaccine Production Capacity, 2018-2029
8.2 Live and Attenuated Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Live and Attenuated Vaccine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Live and Attenuated Vaccine Supply Chain Analysis
10.1 Live and Attenuated Vaccine Industry Value Chain
10.2 Live and Attenuated Vaccine Upstream Market
10.3 Live and Attenuated Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Live and Attenuated Vaccine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LED Light-Up Blanket Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 116 |
Pelvic Floor Functional Magnetic Stimulator Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 115 |
Multi-Modality Biofeedback System Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 112 |
High Frequency Evaluation and Therapy Device Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 115 |
Choose License Type
Why Choose Us ?
24/7 Research support
Quality assurance
Information security
The report efficiently evaluates the market from various dimensions to deliver an
end-product that is informative, elaborate, and accurate and includes detailed
market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast.
The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of
xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the
industry in terms of Value (US$ Mn) and Volume (Thousands Units).
Market is segmented by Types, Applications, Technology, End-use Industries, and Regions.
The report presents the current market size, and market forecast, market
opportunities, key drivers and restraints, regulatory scenario, industry trend, PESTLE
analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing
initiatives, pricing analysis, competitive landscape which help businesses in
decision making. The analysis data is based on current and historical market trends
which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any
organization to gain insight into specific business sector, aligned with specific area
of interest. Thus, SMI offers more accurate, pragmatic, and actionable information
specifically tailored to suit your business needs.
